US Stock MarketDetailed Quotes

HAE Haemonetics

Watchlist
  • 81.240
  • -2.220-2.66%
Close Apr 19 16:00 ET
  • 81.240
  • 0.0000.00%
Post 16:13 ET
4.13BMarket Cap33.02P/E (TTM)

About Haemonetics Company

Haemonetics Corp. engages in the development and distribution of hematology products and solutions. It operates through the following segments: Plasma, Blood Center, Hospital, and Corporate. The Plasma segment offers automated plasma collection and donor management software systems. The Blood Center segment provides solutions for donor collection centers' ability to acquire blood, filter blood, and separate blood components. The Hospital segment includes hemostasis management, cell salvage, and transfusion management services that help decision makers in hospitals optimize blood acquisition, storage, and usage in critical settings. The company was founded by Allen Latham, Jr. in 1971 and is headquartered in Boston, MA.

Company Profile

SymbolHAE
Company NameHaemonetics
Listing DateMay 10, 1991
Issue Price22.00
Founded1971
CEOMr. Christopher A. Simon
MarketNYSE
Employees3034
Securities TypeOrdinary Shares
Fiscal Year Ends03-30
Address125 Summer Street
CityBoston
ProvinceMassachusetts
CountryUnited States of America
Zip Code02110
Phone1-781-848-7100

Company Executives

  • Name
  • Position
  • Salary
  • Christopher A. Simon
  • Director, President and Chief Executive Officer
  • 10.69M
  • Maryanne Maunsell Farris
  • Vice President and Chief Accounting Officer
  • --
  • Anila Lingamneni
  • Executive Vice President and Chief Technology Officer
  • 2.33M
  • James C. D’Arecca
  • Executive Vice President and Chief Financial Officer
  • 3.76M
  • Laurie A. Miller
  • Senior Vice President and Chief Human Resources Officer
  • --
  • Josep L. Llorens
  • Senior Vice President, Global Manufacturing and Supply Chain
  • 2.34M
  • Ellen M. Zane
  • Chairman of the Board
  • 439.95K
  • Roy Galvin
  • President, Global Plasma and Blood Center
  • --
  • Stewart W. Strong
  • President, Global Hospital
  • --
  • Catherine M. Burzik
  • Independent Director
  • 282.95K
  • Robert E. Abernathy
  • Independent Director
  • 284.95K
  • Michael J. Coyle
  • Independent Director
  • 272.95K
  • Dr. Mark W. Kroll,PhD,F.A.C.C.,F.H.R.S.
  • Independent Director
  • 269.95K
  • Lloyd E. Johnson
  • Independent Director
  • 272.95K
  • Charles J. Dockendorff
  • Independent Director
  • 292.95K
  • Dr. Claire Pomeroy, M.B.A.,M.D.
  • Independent Director
  • 269.95K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg